Literature DB >> 10541762

Immunohistochemical localization of selected early response genes expressed in trabecular bone of young rats given hPTH 1-34.

J D Liang1, J M Hock, G E Sandusky, R F Santerre, J E Onyia.   

Abstract

Intermittent administration of parathyroid hormone (PTH) increases trabecular bone mass in vivo by stimulating bone formation. To further characterize the cellular and molecular mediators of the anabolic response to PTH, we examined the effect of intermittent synthetic hPTH 1-34 on the expression and localization of selected early response genes, c-fos, c-jun, c-myc, and IL-6 protein, in bone tissue by immunohistochemistry. Young male Sprague-Dawley rats, 70-100 g, were injected s.c. with 8 microg/100 g PTH or vehicle control, once daily for 5 days. Femurs were harvested 1 and 24 hours after the fifth injection, then fixed, decalcified, processed for wax embedding, and sections were immunostained. Early response genes, c-fos, c-jun and IL-6, were strongly expressed in osteoblasts, osteocytes, and megakaryocytes in bones 1 hour after PTH, when compared with vehicle-treated controls or sections from rats, 24 hours after PTH injection. Osteoblasts, osteocytes, and megakaryocytes were also positive for c-myc but the differences in stain intensity between control and treated groups were marginal. Also, scattered islands of hematopoietic cells in the marrow stained intensely for IL-6 by 1 hour after PTH, but the stain intensity decreased to control level 24 hours after the last PTH injection. Scattered islands of hematopoietic cells in the bone marrow stained more strongly for c-fos than either c-jun or c-myc, but neither localization nor stain intensity were regulated by PTH at the time points examined. We conclude that during the immediate early phase of the anabolic response, PTH regulates c-fos, c-jun, and IL-6 expression in osteoblasts, osteocytes, megakaryocytes, and selected bone marrow hematopoietic cells in bone.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10541762     DOI: 10.1007/s002239900715

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  7 in total

Review 1.  PTH and PTHrP effects on the skeleton.

Authors:  A C Karaplis; D Goltzman
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

2.  Changes in serum runt-related transcription factor 2 levels after a 6-month treatment with recombinant human parathyroid hormone in patients with osteoporosis.

Authors:  W Zhu; M L Yang; G Y Yang; G Boden; L Li
Journal:  J Endocrinol Invest       Date:  2011-11-21       Impact factor: 4.256

3.  Nmp4/CIZ suppresses the response of bone to anabolic parathyroid hormone by regulating both osteoblasts and osteoclasts.

Authors:  Paul Childress; Binu K Philip; Alexander G Robling; Angela Bruzzaniti; Melissa A Kacena; Nicoletta Bivi; Lilian I Plotkin; Aaron Heller; Joseph P Bidwell
Journal:  Calcif Tissue Int       Date:  2011-05-24       Impact factor: 4.333

4.  Hyperlipidemia impairs osteoanabolic effects of PTH.

Authors:  Michael S Huang; Jinxiu Lu; Yevgeniy Ivanov; Andrew P Sage; Wendy Tseng; Linda L Demer; Yin Tintut
Journal:  J Bone Miner Res       Date:  2008-10       Impact factor: 6.741

5.  Malignant myeloma in a patient after treatment for osteoporosis with teriparatide; a rare coincidence.

Authors:  Terje Forslund; Anna-Mari Koski; Arvo Koistinen; Anu Sikiö
Journal:  Clin Med Case Rep       Date:  2008-08-29

Review 6.  GP130 Cytokines in Breast Cancer and Bone.

Authors:  Tolu Omokehinde; Rachelle W Johnson
Journal:  Cancers (Basel)       Date:  2020-01-31       Impact factor: 6.639

7.  The Molecular and Cellular Events That Take Place during Craniofacial Distraction Osteogenesis.

Authors:  Adi Rachmiel; Yoav Leiser
Journal:  Plast Reconstr Surg Glob Open       Date:  2014-02-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.